Compound information
- Natural Products
- ZC320802
- Molecular Formula
- C10H13ClN2O3S
- Molecular Weight
- 276.033540956 g/mol
- Structure
-
- IUPAC Name
- 2-chloro-N-[4-methyl-3-(methylsulfamoyl)phenyl]acetamide
- InChI
- InChI=1S/C10H13ClN2O3S/c1-7-3-4-8(13-10(14)6-11)5-9(7)17(15,16)12-2/h3-5,12H,6H2,1-2H3,(H,13,14)
- InChI Key
- NAIJGHRXJZGLGC-UHFFFAOYSA-N
- SMILES
- CNS(=O)(=O)c1cc(NC(=O)CCl)ccc1C
- Source
- ZINC000008155940
Warheads
- Halohydrocarbon
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 17 | Ring Count | 1 |
Heteroatom Count | 7 | Rotatable Bond Count | 4 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.27 Å2 | LogP | 1.217 |
LogS | -2.689 | LogD | 1.26 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.012 | Pgp substrate | 0.007 |
HIA | 0.96 | F20 % | 0.989 |
F30 % | 0.944 | Caco-2 | -4.999 |
MDCK | -5.765 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.701 | PPB | 77.109 |
VD | 0.503 | Fu | 0.508 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.92 | CYP1A2 substrate | 0.676 |
CYP2A6 substrate | 0.669 | CYP2B6 substrate | 0.612 |
CYP2C19 inhibitor | 0.079 | CYP2C19 substrate | 0.811 |
CYP2C8 substrate | 0.755 | CYP2C9 inhibitor | 0.105 |
CYP2C9 substrate | 0.972 | CYP2D6 inhibitor | 0.013 |
CYP2D6 substrate | 0.812 | CYP2E1 substrate | 0.389 |
CYP3A4 inhibitor | 0.029 | CYP3A4 substrate | 0.95 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.275 | CL | 5.502 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.005 | Hepatotoxicity | 0.959 |
Mutagenicity | 0.055 | Rat Oral Acute Toxicity | 0.124 |
FDAMDD | 0.279 | Skin Sensitization | 0.977 |
Carcinogenicity | 0.124 | Eye Corrosion | 0.002 |
Eye Irritation | 0.042 | Respiratory Toxicity | 0.861 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.506 | IGC50 | 2.993 |
LC50FM | 3.79 | LC50DM | 4.789 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.161 | NR-AR-LBD | 0.493 |
NR-AhR | 0.471 | NR-Aromatase | 0.133 |
NR-ER | 0.447 | NR-ER-LBD | 0.438 |
NR-PPAR-gamma | 0.892 | SR-ARE | 0.974 |
SR-ATAD5 | 0.699 | SR-HSE | 0.274 |
SR-MMP | 0.134 | SR-p53 | 0.765 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.